Skip to Content
 
Center for International Blood and Marrow Transplant Research

P-6402

Main Content

Return to Listing

Blood Advances | 2026

Regional practice differences significantly affect the benefit of post-HCT gilteritinib in FLT3-ITD AML.

Levis MJ, Hamadani M, Logan BR, Jones RJ, Singh AK, Litzow MR, Windgard JR, Papadopoulos EB, Perl AE, Soiffer RJ, Ustun C, Oshima MU, Uy GL, Waller EK, Vasu S, Solh M, Mishra A, Muffly L, Kim HJ, Stelljes M, Najima Y, Onozawa M, Thomson K, Chen C, Hasabou N, Rosales M, Hill J, Gill SC, Nuthethi R, King D, Mendizabal A, Devine SM, Horowitz MM, Chen YB

PubMed
PMID: 42532509

Abstract
Related Articles

CIBMTR Study #: BMT CTN 1506